New Chairman of the Board of Directors elected

Develco Pharma AG has elected a new chairman of its board of directors. The previous chairman, Markus Zimmer, has handed over his office to the newly elected chairman, Steffen Wagner.

Mr. Wagner has broad general management experience in international life science businesses. He is a medical doctor by training, has previously held senior roles with STADA, Biogen and within the Novartis Group, and worked as a consultant at McKinsey and Bain. His industry experience covers Biotech, Pharma, MedTech, Biosimilars, Generics, and OTC. He lead businesses in context of large European-based multinational Pharmaco, US-based Biotech, and Private Equity portfolio companies and likes to work with strong teams to drive business growth, transformation, and M&A.

We wish good cooperation and much success in the new position.